BACKGROUND AND OBJECTIVES: Management of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to elucidate the association between fluid balance, diuretic use, and short-term mortality after AKI in critically ill patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using data from the Fluid and Catheter Treatment Trial (FACTT), a multicenter, randomized controlled trial evaluating a conservative versus liberal fluid-management strategy in 1000 patients with acute lung injury (ALI), we evaluated the association of post-renal injury fluid balance and diuretic use with 60-day mortality in patients who developed AKI, as defined by the AKI Network criteria. RESULTS:306 patients developed AKI in the first 2 study days and were included in our analysis. There were 137 in the fluid-liberal arm and 169 in the fluid-conservative arm (P=0.04). Baseline characteristics were similar between groups. Post-AKI fluid balance was significantly associated with mortality in both crude and adjusted analysis. Higher post-AKI furosemide doses had a protective effect on mortality but no significant effect after adjustment for post-AKI fluid balance. There was no threshold dose of furosemide above which mortality increased. CONCLUSIONS: A positive fluid balance after AKI was strongly associated with mortality. Post-AKI diuretic therapy was associated with 60-day patient survival in FACTT patients with ALI; this effect may be mediated by fluid balance.
RCT Entities:
BACKGROUND AND OBJECTIVES: Management of volume status in patients with acute kidney injury (AKI) is complex, and the role of diuretics is controversial. The primary objective was to elucidate the association between fluid balance, diuretic use, and short-term mortality after AKI in critically ill patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using data from the Fluid and Catheter Treatment Trial (FACTT), a multicenter, randomized controlled trial evaluating a conservative versus liberal fluid-management strategy in 1000 patients with acute lung injury (ALI), we evaluated the association of post-renal injury fluid balance and diuretic use with 60-day mortality in patients who developed AKI, as defined by the AKI Network criteria. RESULTS: 306 patients developed AKI in the first 2 study days and were included in our analysis. There were 137 in the fluid-liberal arm and 169 in the fluid-conservative arm (P=0.04). Baseline characteristics were similar between groups. Post-AKI fluid balance was significantly associated with mortality in both crude and adjusted analysis. Higher post-AKI furosemide doses had a protective effect on mortality but no significant effect after adjustment for post-AKI fluid balance. There was no threshold dose of furosemide above which mortality increased. CONCLUSIONS: A positive fluid balance after AKI was strongly associated with mortality. Post-AKI diuretic therapy was associated with 60-day patient survival in FACTT patients with ALI; this effect may be mediated by fluid balance.
Authors: Greg S Martin; Marc Moss; Arthur P Wheeler; Meredith Mealer; John A Morris; Gordon R Bernard Journal: Crit Care Med Date: 2005-08 Impact factor: 7.598
Authors: Wim Van Biesen; Itir Yegenaga; Raymond Vanholder; Francis Verbeke; Erik Hoste; Francis Colardyn; Norbert Lameire Journal: J Nephrol Date: 2005 Jan-Feb Impact factor: 3.902
Authors: Stuart L Goldstein; Michael J G Somers; Michelle A Baum; Jordan M Symons; Patrick D Brophy; Douglas Blowey; Timothy E Bunchman; Cheryl Baker; Theresa Mottes; Nancy McAfee; Joni Barnett; Gloria Morrison; Kristine Rogers; James D Fortenberry Journal: Kidney Int Date: 2005-02 Impact factor: 10.612
Authors: Shigehiko Uchino; Gordon S Doig; Renaldo Bellomo; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Nacedo; Noel Gibney; Ashita Tolwani; Claudio Ronco; John A Kellum Journal: Crit Care Med Date: 2004-08 Impact factor: 7.598
Authors: Jason A Foland; James D Fortenberry; Barry L Warshaw; Robert Pettignano; Robert K Merritt; Micheal L Heard; Kris Rogers; Chris Reid; April J Tanner; Kirk A Easley Journal: Crit Care Med Date: 2004-08 Impact factor: 7.598
Authors: Greg S Martin; Robert J Mangialardi; Arthur P Wheeler; William D Dupont; John A Morris; Gordon R Bernard Journal: Crit Care Med Date: 2002-10 Impact factor: 7.598
Authors: F Perry Wilson; Michael Shashaty; Jeffrey Testani; Iram Aqeel; Yuliya Borovskiy; Susan S Ellenberg; Harold I Feldman; Hilda Fernandez; Yevgeniy Gitelman; Jennie Lin; Dan Negoianu; Chirag R Parikh; Peter P Reese; Richard Urbani; Barry Fuchs Journal: Lancet Date: 2015-02-26 Impact factor: 79.321